advertisement

Sunday, July 6, 2008
Cancer Center
Breast Cancer
AboutPreventionSymptomsTestsTreatmentManaging

Hormonal treatment

The medications tamoxifen or arimidex are usually prescribed for five years following cancer treatment. Research shows that tamoxifen, which blocks the ability of estrogen to attach to cells and promote their growth, reduces the risk that women who have had a "receptor positive" breast cancer--meaning their cancer cells have hormone receptors--will experience a recurrence of the original cancer or a new cancer. For women who are postmenopausal with early-stage breast cancer that is hormone-receptor positive, arimidex provides greater benefits; it works by reducing the level of estrogen in the blood. Evidence also suggests that for some postmenopausal women who have had receptor-positive breast cancer and completed five years of tamoxifen, taking the aromatase inhibitor letrazole for five additional years may be appropriate.

Graphics
Breast Cancer Need-to-know Anatomy
Multimedia

Health Tips from Dr. Healy:
Video: Why cancer patients should stop smoking

Related Links
Bullet How to lose weight and keep it off
Bullet See eight steps you can take to reduce your risk of cancer
Bullet Breast Cancer-Related Clinical Trials Information
0
Email this sectionEmail this pagePrint this sectionPrint this section
0
0
0

Thee are benefits to taking these medications, but women also experience side effects that can be bothersome and affect quality of life, especially hot flashes and night sweats. If women are experiencing these symptoms they should discuss them with their doctor to learn about different strategies for managing them.

Content last updated: 9/1/05Previous PagePrevious page Next PageNext Page




U.S. News's featured content providers were not involved in the selection of advertisers appearing on this website, and the placement of such advertisement in no way implies that these content providers endorse the products and services advertised. Disclaimer and a note about your health.

advertisement

advertisement

advertisement


Copyright © 2007 U.S.News & World Report, L.P. All rights reserved.

Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.